Patents Assigned to Russell Biotech, Inc.
  • Publication number: 20220195414
    Abstract: CAR T cell therapies have shown promise in treating human blood cell cancer. The preparation of CAR T cells involves many complex, time consuming steps prior to infusion of the CAR T cells into a cancer patient. One step in the process to create CAR T cells often involves using magnetic separation technologies to isolate specific subsets of T cells prior to creating the CAR T cells. When using current magnetic separation technologies to remove undesired cell populations the recovery of the desired cell population can be as low as 50-70% or even lower and the procedures often take 30-60 minutes. In the case of autologous CAR T cell therapies such cell loss is often not acceptable. The present invention offers means to improve the recovery of desired cells to close to 100% very rapidly thus significantly improving a step in the manufacture of CART cells and in many cases will make such therapy possible for a larger patient population.
    Type: Application
    Filed: March 24, 2020
    Publication date: June 23, 2022
    Applicant: Russell Biotech, Inc.
    Inventor: Thomas Russell
  • Patent number: 9790539
    Abstract: Coated Ferromagnetic Density Particles or Density Particles with binding agents bound thereto capable of binding biological molecules and methods of use and apparatus for means are disclosed. Coated particles coupled to specific binding agents can be used for molecular biology and proteomic applications in research and diagnostics.
    Type: Grant
    Filed: June 23, 2005
    Date of Patent: October 17, 2017
    Assignee: Russell Biotech, Inc.
    Inventors: Thomas R. Russell, Michael J. Ciocci, Michael Musick
  • Patent number: 9739768
    Abstract: Methods, apparatus and compositions for separating a desired or undesired population or subpopulation from a biological sample are disclosed herein. The selection procedure is based on ferromagnetic, dense particles in a preferred size range from about 0.8 to about 1.2 microns. Specific binding agents are bound to the particles that recognize and bind to specific molecules on the targeted population or subpopulation, and the particles are mixed with the sample in such a way as to promote movement of the particles relative to the sample, promoting binding to the targeted population or subpopulation without non-specifically binding to non-targeted populations in the sample. Because of the large particle density, the bound population is separated from the fluid sample by gravity.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: August 22, 2017
    Assignee: Russell Biotech, Inc.
    Inventors: Thomas R. Russell, Pauline McGann, Mike Musick, Michael Ciocci
  • Publication number: 20060003371
    Abstract: Coated Ferromagnetic Density Particles or Density Particles with binding agents bound thereto capable of binding biological molecules and methods of use and apparatus for means are disclosed. Coated particles coupled to specific binding agents can be used for molecular biology and proteomic applications in research and diagnostics.
    Type: Application
    Filed: June 23, 2005
    Publication date: January 5, 2006
    Applicant: Russell Biotech, Inc.
    Inventors: Thomas Russell, Michael Ciocci, Michael Musick